Amgen Q4 Earnings: Good Quarter, Ok Guidance, But MariTide Concerns Me (Rating Downgrade)
Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.
Amgen's Broad Portfolio Strength and Wide Moat Should Protect Profits Despite Upcoming Biosimilars
Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...
4AMGN : Amgen Options Trading: A Deep Dive into Market Sentiment
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
Zacks.com on MSN21h
AMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical Hold
AMGN beats fourth-quarter estimates for earnings and sales. FDA places clinical hold on a phase I study on its obesity ...
Hosted on MSN29m
Amgen Earnings Transcript (NASDAQ:AMGN)
Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...